Tadalafil API Manufacturer India: WHO-GMP Certified, IP/BP/USP Grades Available
Global demand for Tadalafil API has never been stronger. As the generic pharma market expands across MENA, Africa, Southeast Asia, and Europe, pharmaceutical companies worldwide are actively searching for a reliable tadalafil API manufacturer in India — one that can supply consistently pure, multi-pharmacopoeia compliant material, backed by complete regulatory documentation and an auditable GMP facility.
This guide answers every question a procurement team or formulation developer needs before placing a tadalafil API order: what to look for in a manufacturer, how Chemox Pharma meets those benchmarks, full technical specifications, available grades, export documentation, and how to request a sample.
What Is Tadalafil API and Why Does It Matter?
Tadalafil Citrate (CAS No. 171596-29-5) is a phosphodiesterase type 5 (PDE5) inhibitor — one of the most clinically proven and commercially significant APIs in the urology and cardiopulmonary space. It is the active ingredient in Cialis (erectile dysfunction) and Adcirca (pulmonary arterial hypertension), two of the world’s most prescribed branded medications, both now widely available in generic form.
Molecular formula: C₂₂H₁₉N₃O₄
Molecular weight: 389.41 g/mol
Appearance: White crystalline powder
Therapeutic class: PDE5 inhibitor
Storage: Room temperature, below 25°C
Mechanism of Action
Tadalafil works by selectively inhibiting cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 in smooth muscle cells of the pulmonary vasculature and corpus cavernosum. By blocking cGMP degradation, it amplifies nitric oxide (NO)-mediated vasodilation, resulting in smooth muscle relaxation and increased blood flow. This dual action — in both urological and cardiopulmonary pathways — makes tadalafil one of the few APIs with multiple approved therapeutic indications from a single molecule.
Clinically, tadalafil is distinguished by its exceptionally long half-life (approximately 17.5 hours) and duration of action of up to 36 hours — earning it the popular descriptor “the weekend pill” in ED treatment. For PAH patients, this translates to once-daily dosing and meaningful quality-of-life benefits over short-acting alternatives.
The Global Tadalafil Market: Why Manufacturers Are Scaling Up
The global tadalafil market is on a strong structural growth trajectory driven by several converging factors:
Generic market expansion: With the branded Cialis patent having expired across major markets, the generic tadalafil segment has seen explosive growth. Generic tadalafil is now the dominant prescribing format in Europe, the Middle East, and increasingly in Africa and Southeast Asia — all of which source APIs primarily from India.
Aging demographics: The global population of men over 40 — the primary demographic for ED treatment — is growing steadily across every major pharmaceutical market. According to market projections, the global PDE5 inhibitor market is expected to exceed USD 6 billion by 2030, with tadalafil holding the largest share.
PAH indication growth: Pulmonary arterial hypertension remains an underserved condition with limited treatment options. Tadalafil’s approved PAH indication (as Adcirca/Tadapox generics) is growing, particularly in hospital formularies across Europe and the Middle East.
Regulatory genericization in emerging markets: African regulatory bodies including NAFDAC (Nigeria), SAHPRA (South Africa), PPB (Kenya), and the SFDA equivalent agencies in the Gulf are increasingly fast-tracking generic approvals for essential medicines — many of which include tadalafil.
All of this creates a sustained, predictable demand for high-quality tadalafil API from WHO-GMP certified Indian manufacturers with established export credentials.
Why India — and Why Chemox Pharma Specifically?
India supplies approximately 60% of the world’s generic pharmaceutical APIs. The country’s combination of advanced process chemistry capabilities, multi-pharmacopoeia compliance infrastructure, cost-competitive large-scale manufacturing, and regulatory depth (with more USFDA-approved facilities than any country outside the US) makes it the default sourcing destination for global pharmaceutical buyers.
Within India’s tadalafil manufacturing landscape, Chemox Pharma Private Limited (CPPL) has established a distinct position as a dedicated, export-focused API manufacturer with the following core attributes that procurement teams look for:
WHO-GMP Certified Manufacturing Facility
Chemox Pharma’s manufacturing facility is located at the Dahej Industrial Estate, Bharuch, Gujarat — one of India’s foremost pharmaceutical and chemical manufacturing corridors. The facility holds WHO-GMP certification and operates under comprehensive Good Laboratory Practice (GLP) and ISO 9001:2015 quality systems.
The Dahej facility is equipped with:
- Multipurpose synthesisreactors designed for complex multi-step organic chemistry
- Dedicated R&D centre for process development and scale-up
- Pilot plant for batch validation before commercial production
- Quality control laboratory with advanced analytical instrumentation (HPLC, GC, ICP-MS, Karl Fischer)
- Environmental controls meeting cGMP standards for temperature, humidity, and contamination prevention
All client audits are welcome. Chemox Pharma operates with a fully open-door audit policy — buyers can schedule facility inspections prior to qualification, a standard requirement for regulated-market procurement.
Multiple Pharmacopoeia Grades — One Supplier
A key procurement pain point in tadalafil API sourcing is finding a single manufacturer who can supply across multiple pharmacopoeia standards. Different export markets require different pharmacopoeia compliance:
| Grade | Primary Markets |
|---|---|
| IP (Indian Pharmacopoeia) | India, South Asia, select African markets |
| BP (British Pharmacopoeia) | UK, Commonwealth markets, East Africa, Middle East |
| EP (European Pharmacopoeia) | European Union, North Africa (EU-aligned markets) |
| USP (United States Pharmacopoeia) | USA, Americas, markets requiring FDA-aligned specs |
Chemox Pharma manufactures and supplies Tadalafil Citrate in all four grades (IP/BP/EP/USP) from the same GMP-certified facility. This means a single qualified supplier relationship covers your entire global market distribution network — simplifying audit workload, documentation management, and supplier diversification risk.
Drug Master File (DMF) Support
For buyers selling into regulated markets (US, EU, Canada, Australia), Drug Master File (DMF) support is non-negotiable. Chemox Pharma files and maintains In-House Drug Master Files (IH-DMFs) for Tadalafil, providing buyers with:
- A reference letter authorizing access to the DMF for regulatory submissions
- Full technical package (impurity profiles, stability data, process validation summary)
- Support for ANDA/NDA filings in the US market
- CEP application guidance for European submissions
Procurement teams should confirm DMF status and filing date during supplier qualification — Chemox Pharma’s QA team can provide this documentation as part of the standard inquiry process.
Tadalafil API Manufacturer India Technical Specifications — Chemox Pharma
| Parameter | Specification |
|---|---|
| Product name | Tadalafil Citrate |
| CAS number | 171596-29-5 |
| Chemical name | (6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino[2′,1′:6,1]pyrido[3,4-b]indole-1,4-dione |
| Molecular formula | C₂₂H₁₉N₃O₄ |
| Molecular weight | 389.41 g/mol |
| Appearance | White to off-white crystalline powder |
| Assay (HPLC) | ≥ 99.0% (as per pharmacopoeia grade) |
| Pharmacopoeia grades | IP / BP / EP / USP |
| Development status | Commercial — available for immediate supply |
| Packaging | 25 kg HDPE drums with double polyethylene liner |
| Storage | Room temperature, below 25°C, away from light and moisture |
| Shelf life | 3 years from date of manufacture |
| IH-DMF | Filed |
| Regulatory certifications | WHO-GMP, GLP, ISO 9001:2015, ISO 14001 |
| Export markets | 20+ countries across MENA, Africa, Asia, Europe |
Quality Control: What Happens Before Every Batch Ships
A common concern among first-time buyers of Indian pharmaceutical APIs is quality consistency — particularly batch-to-batch variation in impurity profiles and assay values. Chemox Pharma’s quality control protocol for Tadalafil Citrate includes:
In-process quality checks:
- Raw material identity and purity testing before synthesis begins
- Intermediate testing at each key reaction stage
- Yield and purity monitoring throughout the synthesis process
Finished product release testing:
- Assay by HPLC (confirmed against pharmacopoeia reference standard)
- Related substances and impurity profiling
- Residual solvents analysis by GC (ICH Q3C compliant)
- Heavy metals and elemental impurities (ICH Q3D compliant)
- Microbial limits and endotoxin testing
- Particle size distribution
- Water content by Karl Fischer titration
- Optical rotation (chiral purity confirmation)
Documentation package per batch:
- Certificate of Analysis (CoA) — full analytical data
- Certificate of Conformance (CoC)
- Stability data on request
- Material Safety Data Sheet (MSDS)
- Regulatory support letter (for DMF reference)
Export Documentation and Regulatory Support
For international buyers, the documentation package accompanying each shipment is as important as the API itself. Chemox Pharma provides a complete export documentation package for every Tadalafil API order:
- Certificate of Analysis (CoA): Full analytical results per lot, signed by QA
- Certificate of Pharmaceutical Product (CPP): Available on request for markets requiring it
- GMP Certificate: Facility GMP certification from competent authority
- Free Sale Certificate: For markets requiring FSC alongside CPP
- Customs documentation: Invoice, packing list, country of origin certificate (CoO)
- Regulatory support letter: For DMF cross-reference in ANDA/NDA/MA filings
The Chemox Pharma business development and regulatory team provides pre-shipment document review support to ensure no documentation gaps at the destination port of entry — a common cause of shipment delays that can disrupt production schedules.
Markets Chemox Pharma Supplies Tadalafil API To
Chemox Pharma currently exports Tadalafil API to pharmaceutical manufacturers across the following geographies:
Middle East and North Africa (MENA):
Egypt, Saudi Arabia, UAE, Jordan, Iraq, Yemen, Morocco, Algeria, Tunisia. The MENA region is among the fastest-growing markets for generic tadalafil, driven by rising awareness, improving healthcare access, and expanding generic formularies.
Sub-Saharan Africa:
Nigeria, Kenya, Tanzania, Ghana, Ethiopia, South Africa. African regulatory bodies are actively approving generic tadalafil products, creating growing demand for GMP-certified API from India.
South and Southeast Asia:
Bangladesh, Sri Lanka, Myanmar, Vietnam, Philippines. Regional formulators are scaling up tadalafil tablet production to serve domestic and export markets.
Europe (select markets):
Eastern Europe and select Western European markets for research and development and small-batch production purposes.
How to Qualify Chemox Pharma as Your Tadalafil API Supplier
Pharmaceutical procurement teams typically follow a structured supplier qualification process before placing a first commercial order. Here is how Chemox Pharma supports each stage:
Stage 1 — Initial inquiry and documentation review
Submit your inquiry via the sample request form or email bd@chemoxpharma.com. Chemox Pharma’s business development team responds within 24 hours with the product technical data sheet, GMP certificate, and CoA from a recent commercial batch.
Stage 2 — Sample request and testing
Request a development sample (typically 100g–500g) for in-house analytical testing against your pharmacopoeia specification. Chemox Pharma ships development samples to qualified buyers with full analytical documentation.
Stage 3 — Facility audit (optional but recommended)
Schedule a virtual or physical facility audit at the Dahej manufacturing site. Chemox Pharma welcomes GMP audits and provides full facility access, documentation review, and QA team meetings.
Stage 4 — Commercial agreement and first order
Agree on commercial terms (pricing, MOQ, lead time, payment terms) and place the first commercial order. Standard lead time for commercial quantities of Tadalafil API is 4–6 weeks from order confirmation.
Stage 5 — Ongoing supply relationship
Chemox Pharma operates as a long-term API supply partner — providing advance batch scheduling, stability updates, regulatory change notifications, and dedicated account management.
Frequently Asked Questions
Q: What is the minimum order quantity (MOQ) for Tadalafil API from Chemox Pharma?
The standard MOQ for commercial orders is 25 kg (one drum). Development samples below 1 kg are available for qualified buyers during the evaluation stage. Please contact our business development team for specific pricing and lead time based on your required quantity.
Q: Does Chemox Pharma hold an IH-DMF for Tadalafil?
Yes. Chemox Pharma has filed an In-House Drug Master File (IH-DMF) for Tadalafil Citrate. A reference authorization letter can be provided to qualified buyers for use in ANDA, NDA, or marketing authorization filings in the US, EU, and other regulated markets.
Q: Which pharmacopoeia grades of Tadalafil does Chemox Pharma supply?
Chemox Pharma supplies Tadalafil Citrate in IP, BP, EP, and USP grades from a single WHO-GMP certified facility. All grades are tested against the respective official pharmacopoeia monographs.
Q: Can Chemox Pharma support USFDA-regulated market submissions?
Yes. While Chemox Pharma’s facility is currently WHO-GMP certified, the company actively supports ANDA filers through its IH-DMF program. Regulatory documentation and technical support for US market submissions is available. Buyers targeting the US market are encouraged to discuss their specific regulatory requirements with our team.
Q: What is the shelf life and storage condition for Tadalafil API?
The approved shelf life is 3 years from the date of manufacture when stored below 25°C, away from direct light and moisture. Full stability data per ICH Q1A guidelines is available on request.
Q: Does Chemox Pharma provide Tadalafil API samples for free?
Development samples are provided at a nominal cost covering material and logistics. Please contact bd@chemoxpharma.com with your company details, required sample quantity, intended use, and destination country to initiate a sample request.
Q: How long does it take to receive a commercial order?
Standard lead time for Tadalafil API in commercial quantities is 4–6 weeks from confirmed purchase order and advance payment. Urgent requirements should be discussed with the BD team for availability of stock inventory.
Why Buyers Choose Chemox Pharma for Tadalafil API
- WHO-GMP certified facility at Dahej, Gujarat — auditable, compliant, transparent
- All major pharmacopoeia grades: IP, BP, EP, USP from a single qualified source
- IH-DMF filed — regulatory support for ANDA and marketing authorization filings
- 99%+ assay purity with full impurity profiling per ICH guidelines
- Complete export documentation — CoA, CoC, CPP, FSC, GMP cert, regulatory letter
- Open audit policy — physical and virtual facility audits welcomed
- Export experience across 20+ countries — MENA, Africa, Asia, Europe
- Dedicated BD and regulatory team — responsive, technically qualified
Request Tadalafil API Sample or Commercial Quote
Chemox Pharma’s business development team is ready to support your tadalafil API sourcing requirement — whether you need a development sample for initial evaluation, technical documentation for regulatory review, or a commercial quotation for ongoing supply.
To get started:
📧 Email: bd@chemoxpharma.com (export and international inquiries)
📞 Call/WhatsApp: +91 9033440410 | +91 9033440407





